Supernus Pharmaceuticals (SUPN) logo

SUPN earnings date, and what happened the last 4 times

Next report

Thu Oct 29

Quality Score today -1

After the close, in 2 days. Confirmed by the company.

SUPN closed higher after 4 of its last 4 reports. On average it closed +4.2% the session after a report.

The moment SUPN reports

  • Its figures, in plain words
  • How it moves after, beside its last four
  • Its Quality Score going in, and after
Get an alert when SUPN reports, with its figures

See it live, free until tomorrow morning. No account. No card. Then keep going with a free account.

What happened after SUPN's last 4 reports

SUPN's last 4 earnings reports
ReportedScore
going in
GapReaction
Oct 19, 20262026 · After close1+0.3%+3.5%
Aug 3, 20262026 · Before open2estimated+13.0%+3.1%
May 5, 20262026 · After close6estimated+3.0%+4.6%
Feb 24, 20262026 · After close10estimated+6.0%+5.7%
  • Oct 19, 2026, after the close: the next session SUPN opened +0.3% and closed +3.5%, and five sessions on it stood +2.3%. Its Quality Score going in was 1 (Below Average).
  • Aug 3, 2026, before the open: that session SUPN opened +13.0% and closed +3.1%, and five sessions on it stood +6.7%. Its Quality Score going in was 2 (Below Average), estimated.
  • May 5, 2026, after the close: the next session SUPN opened +3.0% and closed +4.6%, and five sessions on it stood +2.7%. Its Quality Score going in was 6 (Average), estimated.
  • Feb 24, 2026, after the close: the next session SUPN opened +6.0% and closed +5.7%, and five sessions on it stood +2.4%. Its Quality Score going in was 10 (Average), estimated.

Across these 4 reports SUPN opened higher after 4 of 4 and closed higher after 4 of 4; on average it opened +5.6%, closed +4.2%, and stood +3.5% five sessions on. Its Quality Score is -1 today, against 1 going into its Oct 19, 2026 report.

Gap: where the stock opened the session after the report. Reaction: where that session closed. Both against the close before the report. The largest of the 4: +5.7% after the Feb 24, 2026 report. A score marked estimated was worked out afterwards from that day's prices and filings; Breakaway has recorded every score live since Sep 9 2026.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Pro members see SUPN's reaction live as a report comes out, the release's figures, and an optional alert before it reports.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Questions about SUPN's earnings

As of Oct 27, 2026: Supernus Pharmaceuticals (SUPN): reports Thu Oct 29, after the close. SUPN closed higher after 4 of its last 4 reports. Its Quality Score is -1 (Poor). Scores as of 12:12 AM ET, 15 minutes behind.

When is SUPN's next earnings date?

Reports Thu Oct 29, after the close, a date the company confirmed. SUPN closed higher after 4 of its last 4 reports. Past behavior, not a forecast.

Does SUPN report before or after the market?

SUPN reports Thu Oct 29, after the close. Its last 4 reports came 3 after the close and 1 before the open.

How did SUPN stock react to its last earnings report?

Oct 19, 2026, after the close: the next session SUPN opened +0.3% and closed +3.5%, and five sessions on it stood +2.3%.

Does SUPN stock usually go up after earnings?

SUPN closed higher after 4 of its last 4 reports. On average it closed +4.2% the session after a report, after opening +5.6%. Past behavior, not a forecast.

Supernus Pharmaceuticals' page has its Quality Score, its chart, and its insiders' trades. Everyone reporting beside it: this week's earnings.

Past behavior, not a forecast. The score is delayed at least 15 minutes; the reports' moves are as they closed.

Our top-scored stocks' record: Oct 2021 to Sep 2026, before costs; recorded live since Sep 9 2026.

Breakaway publishes impersonal securities research and analytical tools: one formula, the same score for everyone. It is not personalized investment advice, and nothing here is a recommendation to buy or sell any security.

Market data from a licensed vendor. The age of every quote is shown on the page.

This browser is too old to show this page right. Update it, or open this page in Safari or Chrome.